Thursday, October 04, 2018

New column day

Here, on the corporate sellouts in the Libs' new version of NAFTA - including a little-discussed chapter designed to turn anti-regulatory bias into official policy for an entire continent.

For further reading...
- The text of the USCMA is here, with Chapter 28 (PDF) forming the subject of most of the column. And by way of comparison, I'll point to the "regulatory cooperation" chapter of the CETA, which provides for some level of coordination without the obligation to systematically question domestic regulations.
- I've already linked to some noteworthy USCMA commentary, including pieces from Neil MacDonald, Duncan Cameron and David Moscrop. Janyce McGregor summarizes some of the key changes under the USCMA. Alex Ballingall points out the increase in drug costs arising out of Trudeau's concessions. 
- Finally, for a reminder of the attitude toward regulation driving the U.S.' position, see reporting on the Trump administration's undermining of rules governing asbestos, radiation, and mercury, as well as the Environmental Integrity Project's full list of regulatory slippage under Trump.

No comments:

Post a Comment